OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/ today to join this growing community.
Our Stocks to Watch today include myPhotopipe.com Inc. (OTC: MPPC), SpongeTech® Delivery Systems Inc. (OTCBB: SPNG), Pluristem Therapeutics Inc. (NASDAQ: PSTI), AtheroGenics Inc. (NASDAQ: AGIX), Aspen Technology Inc. (OTC: AZPN)
For the complete newsletter please visit: http://www.otcpicks.com/daily-market-movers/index.php
For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/
MYPHOTOPIPE.COM INCORPORATED (OTC: MPPC)
"Up 20.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MPPC.php
Company Profile: http://www.otcpicks.com/myphotopipe/myphotopipe-2.htm
MyPhotopipe.com Inc. is a US-based provider of online digital photo processing and related services catering to high-end amateur and professional photographers. The Company’s primary web portal is www.myphotopipe.com. Its services include photo finishing and printing, online sharing, photo books, digital photo templates, and online hosting and selling of photographs. The Company provides services to more than 18,500 professional and high-end amateur photographers nationwide; more than 190,000 copies of its software have been downloaded and are in use.
SPONGETECH DELIVERY SYSTEMS (OTCBB: SPNG)
"Up 20.83% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/SPNG.php
SpongeTech Delivery Systems is a production stage company which designs, produces, markets and distributes cleaning products for vehicular use utilizing patented technology relating to sponges containing hydrophilic (liquid absorbing) foam polyurethane matrices. The Company's sponges are specially configured with an outer contact layer and an inner matrix, which is loaded with specially formulated soaps and wax that are released when the sponge is applied to a surface with minimal pressure. The Company's products are currently designed specifically for vehicular cleaning use. However, the Company is exploring the possibility of using its patented technology for the development of sponges for other uses, including for use with anti-bacterial, bath and kitchen soaps for household uses, as well as for use as a children's bath foam sponge.
PLURISTEM THERAPEUTICS (NASD: PSTI)
"Up 28.45% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/PSTI.php
Pluristem Therapeutics, Inc. engages in the research and development of the mesenchymal and stem cell production technology, and the commercialization of cell therapy products. The company is developing a platform designed to create a functional stem cell production system that can treat severe blood, cardiovascular, autoimmune, and other disorders. It develops PluriX Bioreactor System, which is designed to be a system of stromal cell cultures and substrates that creates an artificial physiological environment where mesenchymal stem cells can grow and reproduce outside of the human body without any use of exogenous biologics or pharmacologicals. The company's principal product, PLX-I is intended to resolve the shortfall of matched tissue for bone marrow transplantation by improving the engraftment of hematopoietic stem cells contained umbilical cord blood. Pluristem's products are derived from mesenchymal stem cells obtained from the placenta and expanded in its proprietary PluriX 3D bioreactor that imitates the natural microstructure of bone marrow and does not require supplemental growth factors, cytokines, or other exogenous materials. The company was founded in 2001 as A.I. Software, Inc. and changed its name to Pluristem Life Systems, Inc. in 2003. Further, it changed its name to Pluristem Therapeutics, Inc. in November 2007. Pluristem Therapeutics is based in Haifa, Israel.
ATHEROGENICS INCORPORATED (NASD: AGIX)
"Up 13.36% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/AGIX.php
AtheroGenics, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of chronic inflammatory diseases, including coronary heart disease, organ transplant rejection, rheumatoid arthritis, and asthma. It owns a vascular protectant or v-protectant technology platform to discover drugs. The company's products include AGI-1067, a Phase III clinical trial product for the treatment of atherosclerosis, a coronary heart disease; AGI-1096, a Phase I clinical trial antioxidant and selective anti-inflammatory agent for the treatment of transplant rejection; and other V-Protectant candidates for various chronic inflammatory diseases, including rheumatoid arthritis and asthma. AtheroGenics has collaboration with AstraZeneca for development and commercialization of AGI-1067; and Astellas Pharma, Inc. to develop AGI-1096 as an oral treatment for the prevention of organ transplant rejection. The company was founded in 1993 and is based in Alpharetta, Georgia.
ASPEN TECHNOLOGY INCORPORATED (OTC: AZPN)
"Up 13.92% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/AZPN.php
AspenTech is a leading provider of award-winning process optimization software and services. AspenTech’s integrated aspenONE™ solutions enable manufacturers to reduce costs, increase capacity, and optimize operational performance end-to-end throughout the engineering, plant operations, and supply chain management processes. For more information, visit www.aspentech.com.
About OTCPicks.com
OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCPicks.com has been compensated four hundred thousand free trading shares from a non-controlling third party for MPPC advertising and promotional services. OTCPicks.com has been compensated seventeen thousand dollars by the company and four hundred thousand free trading shares by a non-controlling third party for multiple 30-day SPNG IR programs.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
